Hardware, Equipment & Parts
Compare Stocks
4 / 10Stock Comparison
CPSH vs AMAT vs ACMR vs MKSI
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Hardware, Equipment & Parts
CPSH vs AMAT vs ACMR vs MKSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Semiconductors | Semiconductors | Hardware, Equipment & Parts |
| Market Cap | $57M | $325.54B | $3.92B | $20.25B |
| Revenue (TTM) | $32M | $28.37B | $901M | $4.07B |
| Net Income (TTM) | $30K | $7.00B | $94M | $327M |
| Gross Margin | 14.5% | 48.7% | 44.4% | 45.2% |
| Operating Margin | -0.6% | 29.2% | 12.1% | 14.8% |
| Forward P/E | 137.4x | 37.1x | 29.7x | 30.4x |
| Total Debt | $336K | $6.55B | $303M | $4.69B |
| Cash & Equiv. | $4M | $7.24B | $766M | $675M |
CPSH vs AMAT vs ACMR vs MKSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CPS Technologies Co… (CPSH) | 100 | 264.1 | +164.1% |
| Applied Materials, … (AMAT) | 100 | 730.7 | +630.7% |
| ACM Research, Inc. (ACMR) | 100 | 297.0 | +197.0% |
| MKS Inc. (MKSI) | 100 | 284.8 | +184.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CPSH vs AMAT vs ACMR vs MKSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CPSH is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 54.3%, EPS growth 112.4%, 3Y rev CAGR 7.0%
- Lower volatility, beta 1.06, Low D/E 1.4%, current ratio 5.30x
- Beta 1.06, current ratio 5.30x
- 54.3% revenue growth vs AMAT's 4.4%
AMAT carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 8 yrs, beta 2.14, yield 0.4%
- 24.7% margin vs CPSH's 0.1%
- 0.4% yield, 8-year raise streak, vs ACMR's 0.2%, (1 stock pays no dividend)
- 19.3% ROA vs CPSH's 0.1%, ROIC 33.3% vs 2.1%
ACMR is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 30.7% 10Y total return vs AMAT's 20.1%
- PEG 0.84 vs AMAT's 2.16
- Lower P/E (29.7x vs 37.1x), PEG 0.84 vs 2.16
MKSI is the clearest fit if your priority is momentum.
- +306.1% vs CPSH's +118.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 54.3% revenue growth vs AMAT's 4.4% | |
| Value | Lower P/E (29.7x vs 37.1x), PEG 0.84 vs 2.16 | |
| Quality / Margins | 24.7% margin vs CPSH's 0.1% | |
| Stability / Safety | Beta 1.06 vs ACMR's 3.24, lower leverage | |
| Dividends | 0.4% yield, 8-year raise streak, vs ACMR's 0.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +306.1% vs CPSH's +118.0% | |
| Efficiency (ROA) | 19.3% ROA vs CPSH's 0.1%, ROIC 33.3% vs 2.1% |
CPSH vs AMAT vs ACMR vs MKSI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CPSH vs AMAT vs ACMR vs MKSI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMAT leads in 3 of 6 categories
ACMR leads 2 • CPSH leads 0 • MKSI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMAT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMAT is the larger business by revenue, generating $28.4B annually — 883.2x CPSH's $32M. AMAT is the more profitable business, keeping 24.7% of every revenue dollar as net income compared to CPSH's 0.1%. On growth, MKSI holds the edge at +15.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $32M | $28.4B | $901M | $4.1B |
| EBITDAEarnings before interest/tax | $85,428 | $8.4B | $126M | $945M |
| Net IncomeAfter-tax profit | $30,213 | $7.0B | $94M | $327M |
| Free Cash FlowCash after capex | -$767M | $5.7B | -$69M | $401M |
| Gross MarginGross profit ÷ Revenue | +14.5% | +48.7% | +44.4% | +45.2% |
| Operating MarginEBIT ÷ Revenue | -0.6% | +29.2% | +12.1% | +14.8% |
| Net MarginNet income ÷ Revenue | +0.1% | +24.7% | +10.4% | +8.0% |
| FCF MarginFCF ÷ Revenue | -23.9% | +20.1% | -7.6% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.4% | -3.5% | +9.4% | +15.2% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +13.9% | -76.1% | +53.2% |
Valuation Metrics
ACMR leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 43.2x trailing earnings, ACMR trades at a 69% valuation discount to CPSH's 137.4x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs AMAT's 2.76x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $57M | $325.5B | $3.9B | $20.2B |
| Enterprise ValueMkt cap + debt − cash | $53M | $324.9B | $3.5B | $24.3B |
| Trailing P/EPrice ÷ TTM EPS | 137.36x | 47.40x | 43.21x | 68.83x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 37.07x | 29.68x | 30.36x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.76x | 1.22x | — |
| EV / EBITDAEnterprise value multiple | 119.84x | 38.68x | 27.49x | 26.70x |
| Price / SalesMarket cap ÷ Revenue | 1.76x | 11.48x | 4.35x | 5.15x |
| Price / BookPrice ÷ Book value/share | 2.23x | 16.25x | 2.06x | 7.49x |
| Price / FCFMarket cap ÷ FCF | — | 57.13x | — | 40.74x |
Profitability & Efficiency
AMAT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
AMAT delivers a 34.3% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $0 for CPSH. CPSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), AMAT scores 7/9 vs ACMR's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.2% | +34.3% | +6.1% | +12.2% |
| ROA (TTM)Return on assets | +0.1% | +19.3% | +3.9% | +3.7% |
| ROICReturn on invested capital | +2.1% | +33.3% | +7.0% | +6.5% |
| ROCEReturn on capital employed | +2.3% | +30.6% | +6.6% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 2 | 6 |
| Debt / EquityFinancial leverage | 0.01x | 0.32x | 0.16x | 1.73x |
| Net DebtTotal debt minus cash | -$4M | -$686M | -$463M | $4.0B |
| Cash & Equiv.Liquid assets | $4M | $7.2B | $766M | $675M |
| Total DebtShort + long-term debt | $336,000 | $6.6B | $303M | $4.7B |
| Interest CoverageEBIT ÷ Interest expense | — | 35.46x | 20.44x | 2.84x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMAT five years ago would be worth $31,383 today (with dividends reinvested), compared to $5,725 for CPSH. Over the past 12 months, MKSI leads with a +306.1% total return vs CPSH's +118.0%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs CPSH's 10.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +17.2% | +52.9% | +31.9% | +78.8% |
| 1-Year ReturnPast 12 months | +118.0% | +164.7% | +195.6% | +306.1% |
| 3-Year ReturnCumulative with dividends | +34.9% | +258.7% | +487.9% | +266.0% |
| 5-Year ReturnCumulative with dividends | -42.7% | +213.8% | +133.4% | +66.5% |
| 10-Year ReturnCumulative with dividends | +108.3% | +2014.4% | +3065.8% | +750.6% |
| CAGR (3Y)Annualised 3-year return | +10.5% | +53.1% | +80.5% | +54.1% |
Risk & Volatility
Evenly matched — CPSH and AMAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CPSH is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than ACMR's 3.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMAT currently trades 94.8% from its 52-week high vs CPSH's 54.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.06x | 2.14x | 3.24x | 2.64x |
| 52-Week HighHighest price in past year | $6.85 | $432.81 | $71.65 | $326.83 |
| 52-Week LowLowest price in past year | $1.63 | $151.51 | $19.26 | $71.49 |
| % of 52W HighCurrent price vs 52-week peak | +54.7% | +94.8% | +82.6% | +92.0% |
| RSI (14)Momentum oscillator 0–100 | 32.8 | 66.3 | 60.7 | 65.3 |
| Avg Volume (50D)Average daily shares traded | 259K | 6.0M | 1.2M | 1.2M |
Analyst Outlook
AMAT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AMAT as "Buy", ACMR as "Buy", MKSI as "Buy". Consensus price targets imply 3.9% upside for AMAT (target: $426) vs -32.4% for ACMR (target: $40). For income investors, AMAT offers the higher dividend yield at 0.42% vs ACMR's 0.19%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $426.39 | $40.00 | $272.86 |
| # AnalystsCovering analysts | — | 53 | 10 | 29 |
| Dividend YieldAnnual dividend ÷ price | — | +0.4% | +0.2% | +0.3% |
| Dividend StreakConsecutive years of raises | — | 8 | 3 | 0 |
| Dividend / ShareAnnual DPS | — | $1.71 | $0.11 | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.5% | +0.2% | +0.2% |
AMAT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACMR leads in 2 (Valuation Metrics, Total Returns). 1 tied.
CPSH vs AMAT vs ACMR vs MKSI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CPSH or AMAT or ACMR or MKSI a better buy right now?
For growth investors, CPS Technologies Corporation (CPSH) is the stronger pick with 54.
3% revenue growth year-over-year, versus 4. 4% for Applied Materials, Inc. (AMAT). ACM Research, Inc. (ACMR) offers the better valuation at 43. 2x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate Applied Materials, Inc. (AMAT) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CPSH or AMAT or ACMR or MKSI?
On trailing P/E, ACM Research, Inc.
(ACMR) is the cheapest at 43. 2x versus CPS Technologies Corporation at 137. 4x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus Applied Materials, Inc. 's 2. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CPSH or AMAT or ACMR or MKSI?
Over the past 5 years, Applied Materials, Inc.
(AMAT) delivered a total return of +213. 8%, compared to -42. 7% for CPS Technologies Corporation (CPSH). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus CPSH's +108. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CPSH or AMAT or ACMR or MKSI?
By beta (market sensitivity over 5 years), CPS Technologies Corporation (CPSH) is the lower-risk stock at 1.
06β versus ACM Research, Inc. 's 3. 24β — meaning ACMR is approximately 206% more volatile than CPSH relative to the S&P 500. On balance sheet safety, CPS Technologies Corporation (CPSH) carries a lower debt/equity ratio of 1% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CPSH or AMAT or ACMR or MKSI?
By revenue growth (latest reported year), CPS Technologies Corporation (CPSH) is pulling ahead at 54.
3% versus 4. 4% for Applied Materials, Inc. (AMAT). On earnings-per-share growth, the picture is similar: CPS Technologies Corporation grew EPS 112. 4% year-over-year, compared to -10. 5% for ACM Research, Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CPSH or AMAT or ACMR or MKSI?
Applied Materials, Inc.
(AMAT) is the more profitable company, earning 24. 7% net margin versus 1. 3% for CPS Technologies Corporation — meaning it keeps 24. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMAT leads at 29. 2% versus 1. 4% for CPSH. At the gross margin level — before operating expenses — AMAT leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CPSH or AMAT or ACMR or MKSI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus Applied Materials, Inc. 's 2. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACM Research, Inc. (ACMR) trades at 29. 7x forward P/E versus 37. 1x for Applied Materials, Inc. — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMAT: 3. 9% to $426. 39.
08Which pays a better dividend — CPSH or AMAT or ACMR or MKSI?
In this comparison, AMAT (0.
4% yield), MKSI (0. 3% yield), ACMR (0. 2% yield) pay a dividend. CPSH does not pay a meaningful dividend and should not be held primarily for income.
09Is CPSH or AMAT or ACMR or MKSI better for a retirement portfolio?
For long-horizon retirement investors, CPS Technologies Corporation (CPSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
06), +108. 3% 10Y return). Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CPSH: +108. 3%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CPSH and AMAT and ACMR and MKSI?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CPSH is a small-cap high-growth stock; AMAT is a large-cap quality compounder stock; ACMR is a small-cap high-growth stock; MKSI is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.